Peroxisome dysfunction alters metabolism of photoreceptor outer segments in human retinal pigment epithelium

This study demonstrates that peroxisome dysfunction caused by PEX1 or PEX6 mutations in human retinal pigment epithelium disrupts lipid metabolism and photoreceptor outer segment processing, providing a mechanistic explanation for retinal degeneration in peroxisome biogenesis disorders.

The Gist

The Big Picture: A Broken Recycling Plant in the Eye

Imagine your eye is a bustling city, and the Retinal Pigment Epithelium (RPE) is the city's sanitation department. Its most important job is to constantly clean up the "trash" left behind by the city's most energetic workers: the photoreceptors (the cells that let you see). Every day, these workers shed their outer tips, and the RPE must eat, digest, and recycle them to keep the city running smoothly.

Inside the RPE cells, there are tiny, specialized machines called peroxisomes. Think of these peroxisomes as the specialized recycling centers of the cell. Their specific job is to break down very long, complex, and "sticky" chains of fat (fatty acids) that the regular trash trucks (mitochondria) can't handle.

The Problem:
In patients with a rare group of genetic diseases called Peroxisome Biogenesis Disorders (PBDs), these recycling centers are broken. Specifically, the paper focuses on two broken machines: PEX1 and PEX6. Without them, the recycling center can't import the tools it needs to do its job.

The Discovery:
The researchers created a "mini-eye" in a dish using human stem cells. They made two versions:

1. Healthy RPE: With working recycling centers.
2. Sick RPE: With broken PEX1 and PEX6 machines.

They found that even though the "sick" cells looked normal at first, the moment they tried to do their job (cleaning up the photoreceptor trash), everything fell apart.

---

The Four Main Ways the System Failed

Here is what happened when the broken cells tried to clean up the trash, explained through analogies:

1. The Clogged Drain (Lipid Buildup)

• What happened: Because the recycling centers were broken, the long, sticky fat chains couldn't be chopped up. Instead of being recycled, they piled up inside the cell like grease clogging a kitchen sink.
• The Analogy: Imagine a garbage truck trying to dump a load of heavy, wet cement. If the truck's compactor is broken, the cement just sits there, getting heavier and heavier until the truck can't move. In the sick cells, this "cement" (fat) formed giant blobs called lipid droplets, making the cell sluggish and toxic.

2. The Wrong Ingredients (Missing Omega-3s)

• What happened: The retina needs a special type of fat called DHA (an Omega-3 fatty acid) to stay flexible and work properly. Usually, the cell takes a longer version of this fat and uses the peroxisome to "shave it down" (retroconvert) into the perfect size.
• The Analogy: Think of the peroxisome as a hair salon. The cell brings in a long, unruly wig (a long-chain fat), and the salon cuts it into a stylish, perfect bob (DHA). In the sick cells, the scissors were broken. The salon couldn't cut the hair. As a result, the cell ended up with a pile of uncut, long wigs and a shortage of the perfect bobs it needed to function.

3. The Clogged Trash Chute (Failed Phagocytosis)

• What happened: The RPE is supposed to swallow the photoreceptor tips (POS) and digest them. In the sick cells, they could grab the trash, but they couldn't digest it. The trash sat inside the cell, rotting.
• The Analogy: Imagine a vacuum cleaner that can suck up dust but has a broken bag. It sucks up the dirt, but the dirt just sits in the hose, blocking the airflow. Eventually, the vacuum stops working entirely. The sick cells tried to eat the trash, but because their internal "digestive acid" (lysosomes) wasn't working right, the trash piled up, causing the cell to become stressed and leaky.

4. The Leaky Wall (Loss of Barrier)

• What happened: When the sick cells were overwhelmed with trash, their outer walls (tight junctions) started to fall apart.
• The Analogy: Think of the RPE layer as a brick wall holding back a flood. When the bricks (cells) get clogged with garbage and stressed, the mortar between them cracks. The wall becomes leaky, and the protective barrier of the eye fails. This is likely why patients with these diseases go blind—the "wall" protecting their vision collapses.

---

Why Does This Matter?

Before this study, scientists knew that PBDs caused blindness, but they didn't know exactly why the eye failed. They thought maybe the cells just died because they were sick.

This study showed something new: The cells are actually quite tough. They can grow and look normal on their own. But, the moment they are asked to do their specific job—recycling the fat-rich trash of the eye—they fail miserably.

The Takeaway:
The eye is a high-performance engine that runs on a very specific, high-octane fuel (fats). If the specialized recycling plant (peroxisomes) breaks, the engine doesn't just stop; it gets gummed up with sludge, loses its essential lubricants, and eventually explodes.

This research gives scientists a new "mini-eye" model to test drugs. If we can find a way to help these broken recycling centers work better, or help the cells manage the fat buildup, we might be able to prevent the blindness associated with these rare genetic disorders.

Technical Summary

1. Problem Statement

Peroxisome Biogenesis Disorders (PBDs) are recessive genetic diseases caused by mutations in PEX genes, leading to impaired peroxisome assembly and function. While PBDs cause severe multisystemic issues (brain, liver, kidneys), retinal degeneration and blindness are common clinical features. Specifically, mutations in PEX1 and PEX6 account for 75% of PBD cases.

• The Gap: Although mouse models show that peroxisome dysfunction impairs photoreceptor outer segment (POS) phagocytosis and fatty acid metabolism in the Retinal Pigment Epithelium (RPE), the precise molecular mechanisms in human RPE cells remain poorly understood.
• The Challenge: The RPE is a highly bioenergetic tissue responsible for phagocytosing and metabolizing POS, which are rich in very long-chain fatty acids (VLCFAs) and polyunsaturated fatty acids (PUFAs). It is unclear how the loss of peroxisomal function specifically disrupts human RPE lipid metabolism and cellular health.

2. Methodology

The authors developed the first human induced pluripotent stem cell-derived RPE (iRPE) models to study peroxisome dysfunction in a disease-relevant cell type.

• Cell Models:
  • Generated isogenic PEX1 knockout (PEX1-/-) and PEX6 knockout (PEX6-/-) iPSC lines using CRISPR/Cas9 from a wildtype (WT) human iPSC line.
  • Differentiated all three lines (WT, PEX1-/-, PEX6-/-) into mature RPE using a standardized protocol involving nicotinamide, Activin-A, and CHIR99021.
• Characterization of Differentiation:
  • Verified RPE maturation via expression of signature proteins (TYRP1, PAX6, PMEL17, BEST1, MITF) using flow cytometry and immunofluorescence.
  • Assessed morphological features (pigmentation, hexagonal shape, tight junctions via ZO-1) and barrier function (Transepithelial Electrical Resistance, TEER).
• Validation of Peroxisome Dysfunction:
  • Confirmed protein knockdown via Western blot.
  • Assessed peroxisome matrix protein import using a GFP-PTS1 reporter (GFP-SKL) in iPSCs.
  • Analyzed proteolytic processing of peroxisomal $\beta$-oxidation enzymes (ACOX1, MFP2, ACAA1) which require peroxisomal import for activation.
• Lipidomic Profiling:
  • Used Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-MS/MS (LC-MS/MS) to quantify fatty acids, plasmalogens, and acylcarnitines.
  • Measured specific markers: VLCFAs (C26:0), branched-chain fatty acids (pristanic and phytanic acid), and plasmalogens.
• Phagocytosis and Metabolism Assays:
  • POS Challenge: Exposed iRPE to bovine photoreceptor outer segments (POS) to simulate physiological burden.
  • Lipid Accumulation: Quantified neutral lipids using LipidTOX Deep Red and Perilipin-2 (PLIN2) levels.
  • Retroconversion: Measured the conversion of DHA (C22:6$\omega$3) to EPA (C20:5$\omega$3) and DPA$\omega$6 (C22:5$\omega$6) to AA (C20:4$\omega$6), processes dependent on peroxisomal $\beta$-oxidation.
  • Phagocytosis Efficiency: Used pHrodo-labeled POS (pH-sensitive dye) and flow cytometry to track POS uptake and trafficking to acidic lysosomal compartments.
  • Lysosomal Function: Assessed Cathepsin D maturation and TEER changes after POS challenge.

3. Key Contributions

• First Human iRPE Models for PBDs: Established and characterized PEX1-/- and PEX6-/- human iRPE lines, providing a robust in vitro platform to study PBD pathology in a human retinal context.
• Decoupling Maturation from Metabolism: Demonstrated that peroxisome dysfunction does not prevent the differentiation of iPSCs into mature, functional RPE cells (pigmented, polarized, high TEER), but severely compromises their metabolic response to physiological stress (POS).
• Mechanistic Insight into Retinal Degeneration: Identified that the primary driver of RPE failure in PBDs is the inability to metabolize POS-derived lipids, leading to toxic accumulation and lysosomal dysfunction.

4. Key Results

A. Cell Maturation and Peroxisome Integrity

• PEX1-/- and PEX6-/- iRPE successfully differentiated into mature RPE, expressing all signature markers and forming tight junctions with TEER comparable to WT.
• Import Defect: Both mutant lines showed a global failure in peroxisome matrix protein import.
  • GFP-PTS1 remained cytosolic (diffuse) rather than punctate (peroxisomal).
  • Enzymes ACOX1, MFP2, and ACAA1 failed to undergo proteolytic cleavage (required for activation), remaining in their inactive precursor forms.
• Protein Stability: PEX1 and PEX6 proteins were mutually dependent; loss of one led to the degradation of the other. PEX5 (the cargo receptor) was also reduced.
• Peroxisome Number: Unlike some fibroblast models, the number of peroxisomes per cell was not significantly reduced, suggesting the RPE may upregulate biogenesis to compensate for dysfunction.

B. Lipidomic Abnormalities

• VLCFA Accumulation: Massive increases in C26:0 (24-17x) and C26:1$\omega$9 (34-29x) were observed, recapitulating the clinical biomarker profile of PBDs.
• Plasmalogen Deficit: Significant reduction in PE-plasmalogens (8.8-9.9x decrease), essential for membrane integrity.
• BCFA Toxicity: Extreme accumulation of branched-chain fatty acids: Pristanic acid (96x) and Phytanic acid (13x).
• Lipid Droplets: Mutant cells showed increased intracellular neutral lipids and PLIN2-positive lipid droplets, which persisted and increased further after POS challenge, indicating a failure to oxidize fatty acids.

C. Impaired POS Metabolism and Retroconversion

• Retroconversion Failure: In WT cells, POS challenge led to the generation of EPA (from DHA) and AA (from DPA$\omega$6) via peroxisomal $\beta$-oxidation. PEX1-/- and PEX6-/- cells failed to produce these retroconversion products.
• Substrate Accumulation: Mutant cells accumulated significantly higher levels of DPA$\omega$6 (the precursor) compared to WT, confirming a block in the retroconversion pathway rather than a lack of substrate.
• DHA Levels: While baseline DHA was lower in mutants, all lines accumulated DHA to similar levels after POS challenge, suggesting the RPE can buffer DHA levels but cannot process the excess via retroconversion.

D. Phagocytosis and Cellular Health

• Degradation Defect: While initial POS uptake was similar at baseline, mutant cells failed to degrade rhodopsin efficiently. After 24 hours, significantly more rhodopsin remained in mutant cells compared to WT.
• Trafficking Defect: pHrodo-POS assays revealed that mutant cells had reduced trafficking of POS to acidic lysosomal compartments.
• Lysosomal Dysfunction: Mutant cells showed impaired maturation of Cathepsin D (a key lysosomal protease) after POS challenge.
• Barrier Collapse: Upon POS challenge, PEX1-/- and PEX6-/- iRPE suffered a >50% reduction in TEER, indicating loss of barrier integrity and cellular health, whereas WT cells maintained integrity.

5. Significance

• Novel Disease Mechanism: The study establishes that in human RPE, peroxisome dysfunction leads to retinal degeneration not merely through general toxicity, but specifically through the failure to metabolize photoreceptor outer segments. The inability to perform $\beta$-oxidation of VLCFAs and branched-chain fatty acids leads to lipid accumulation, lysosomal dysfunction, and subsequent barrier failure.
• Retroconversion Pathway: It highlights the critical, previously underappreciated role of peroxisomes in the RPE for the retroconversion of long-chain PUFAs (DHA/DPA) into shorter-chain forms (EPA/AA), a process essential for maintaining retinal lipid homeostasis.
• Therapeutic Implications: The findings suggest that therapeutic strategies for PBD-related retinal degeneration should focus on:
  1. Reducing the lipid burden on the RPE (e.g., dietary restriction of phytanic/pristanic acids).
  2. Enhancing alternative lipid oxidation pathways.
  3. Supporting lysosomal function to improve POS clearance.
• Model Utility: The generated iRPE lines serve as a powerful in vitro platform for screening drugs targeting peroxisomal metabolism and lipid handling in the retina.